Comparison of Humoral Immune Response to SARS-CoV-2 Infection and/or Immunization in Primary Immunodeficient, Rheumatic and Healthy Individuals

Genalyte Inc published this content on October 27, 2022, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 15, 2026 at 07:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]